Titre : Virus non classés

Virus non classés : Questions médicales fréquentes

Termes MeSH sélectionnés :

Controlled Substances
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virus non classés : Questions médicales les plus fréquentes", "headline": "Virus non classés : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virus non classés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-11", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virus non classés" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Virus", "url": "https://questionsmedicales.fr/mesh/D014780", "about": { "@type": "MedicalCondition", "name": "Virus", "code": { "@type": "MedicalCode", "code": "D014780", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Anellovirus", "alternateName": "Anelloviridae", "url": "https://questionsmedicales.fr/mesh/D049811", "about": { "@type": "MedicalCondition", "name": "Anellovirus", "code": { "@type": "MedicalCode", "code": "D049811", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.970.270" } } }, { "@type": "MedicalWebPage", "name": "Nanovirus", "alternateName": "Nanovirus", "url": "https://questionsmedicales.fr/mesh/D025682", "about": { "@type": "MedicalCondition", "name": "Nanovirus", "code": { "@type": "MedicalCode", "code": "D025682", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.970.540" } } }, { "@type": "MedicalWebPage", "name": "Picobirnavirus", "alternateName": "Picobirnavirus", "url": "https://questionsmedicales.fr/mesh/D018708", "about": { "@type": "MedicalCondition", "name": "Picobirnavirus", "code": { "@type": "MedicalCode", "code": "D018708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.970.610" } } } ], "about": { "@type": "MedicalCondition", "name": "Virus non classés", "alternateName": "Viruses, Unclassified", "code": { "@type": "MedicalCode", "code": "D014713", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Thomas Skovhus Prior", "url": "https://questionsmedicales.fr/author/Thomas%20Skovhus%20Prior", "affiliation": { "@type": "Organization", "name": "Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark. thbjer@rm.dk." } }, { "@type": "Person", "name": "Charlotte Hyldgaard", "url": "https://questionsmedicales.fr/author/Charlotte%20Hyldgaard", "affiliation": { "@type": "Organization", "name": "Diagnostic Center, University Research Clinic for Innovative Patient Pathways, Silkeborg Regional Hospital, Silkeborg, Denmark." } }, { "@type": "Person", "name": "Claudia Ganter", "url": "https://questionsmedicales.fr/author/Claudia%20Ganter", "affiliation": { "@type": "Organization", "name": "Centre for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Centre for Lung Research, Heidelberg, Germany." } }, { "@type": "Person", "name": "Elisabeth Bendstrup", "url": "https://questionsmedicales.fr/author/Elisabeth%20Bendstrup", "affiliation": { "@type": "Organization", "name": "Centre for Rare Lung Diseases, Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark." } }, { "@type": "Person", "name": "Michael Kreuter", "url": "https://questionsmedicales.fr/author/Michael%20Kreuter", "affiliation": { "@type": "Organization", "name": "Centre for Interstitial and Rare Lung Diseases, Pneumology, Thoraxklinik, University of Heidelberg and German Centre for Lung Research, Heidelberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35987353", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuropharm.2022.109220" } }, { "@type": "ScholarlyArticle", "name": "Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis.", "datePublished": "2023-01-30", "url": "https://questionsmedicales.fr/article/36738634", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.drugalcdep.2023.109788" } }, { "@type": "ScholarlyArticle", "name": "The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews.", "datePublished": "2024-05-07", "url": "https://questionsmedicales.fr/article/38715038", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-024-11040-w" } }, { "@type": "ScholarlyArticle", "name": "Impact of mandatory COVID-19 shelter-in-place order on controlled substance use among rural versus urban communities in the United States.", "datePublished": "2022-06-16", "url": "https://questionsmedicales.fr/article/35710976", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jrh.12688" } }, { "@type": "ScholarlyArticle", "name": "Cardiopulmonary and muscular effects of different doses of high-intensity physical training in substance use disorder patients: study protocol for a block allocated controlled endurance and strength training trial in an inpatient setting.", "datePublished": "2022-09-27", "url": "https://questionsmedicales.fr/article/36167363", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-061014" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus non classés", "item": "https://questionsmedicales.fr/mesh/D014713" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virus non classés - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virus non classés", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Virus non classés", "description": "Comment diagnostiquer un virus non classé ?\nQuels tests sont utilisés pour ces virus ?\nLes virus non classés peuvent-ils être détectés par sérologie ?\nQuels symptômes peuvent indiquer un virus non classé ?\nPeut-on identifier un virus non classé par biopsie ?", "url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Controlled+Substances&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Virus non classés", "description": "Quels sont les symptômes courants des virus non classés ?\nLes symptômes varient selon le virus ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes peuvent-ils être confondus avec d'autres infections ?\nLes symptômes persistent-ils longtemps ?", "url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Controlled+Substances&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Virus non classés", "description": "Comment prévenir les infections par des virus non classés ?\nLes vaccins existent-ils pour ces virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir la transmission ?\nFaut-il éviter certains aliments pour prévenir ces virus ?", "url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Controlled+Substances&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Virus non classés", "description": "Quels traitements sont disponibles pour les virus non classés ?\nLes antiviraux sont-ils efficaces contre ces virus ?\nComment gérer les symptômes d'une infection virale non classée ?\nDes traitements expérimentaux existent-ils ?\nLes antibiotiques sont-ils utiles contre ces virus ?", "url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Controlled+Substances&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Virus non classés", "description": "Quelles complications peuvent survenir avec ces virus ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications d'une infection virale ?\nLes complications peuvent-elles être évitées ?\nY a-t-il des risques à long terme associés ?", "url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Controlled+Substances&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Virus non classés", "description": "Quels sont les facteurs de risque pour ces virus ?\nLes voyages augmentent-ils le risque d'infection ?\nLe contact avec des animaux est-il un facteur de risque ?\nLes conditions de vie influencent-elles le risque ?\nL'âge joue-t-il un rôle dans le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014713?mesh_terms=Controlled+Substances&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un virus non classé ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests PCR, sérologiques et l'analyse des symptômes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour ces virus ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les cultures cellulaires sont couramment utilisés pour l'identification." } }, { "@type": "Question", "name": "Les virus non classés peuvent-ils être détectés par sérologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sérologiques peuvent aider à détecter des anticorps spécifiques." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un virus non classé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais incluent souvent fièvre, fatigue et troubles respiratoires." } }, { "@type": "Question", "name": "Peut-on identifier un virus non classé par biopsie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie peut être utile, mais elle n'est pas la méthode principale de diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des virus non classés ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, douleurs musculaires, fatigue et troubles respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient selon le virus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus non classé peut provoquer des symptômes différents selon son type." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques à surveiller ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Surveillez les symptômes respiratoires sévères et les signes de déshydratation." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres infections ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent ressembler à ceux d'autres infections virales courantes." } }, { "@type": "Question", "name": "Les symptômes persistent-ils longtemps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La durée des symptômes varie, mais certains peuvent persister plusieurs semaines." } }, { "@type": "Question", "name": "Comment prévenir les infections par des virus non classés ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut l'hygiène, la vaccination si disponible et l'évitement des contacts." } }, { "@type": "Question", "name": "Les vaccins existent-ils pour ces virus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Peu de vaccins sont disponibles, car ces virus sont souvent mal compris." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Lavez-vous les mains régulièrement et évitez de toucher votre visage." } }, { "@type": "Question", "name": "Les masques aident-ils à prévenir la transmission ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les masques peuvent réduire la transmission, surtout dans les zones à risque." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments pour prévenir ces virus ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments crus ou mal cuits, surtout dans les zones d'épidémie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les virus non classés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitements spécifiques; les soins sont généralement symptomatiques." } }, { "@type": "Question", "name": "Les antiviraux sont-ils efficaces contre ces virus ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux peuvent être inefficaces, car ces virus ne répondent pas toujours aux traitements standards." } }, { "@type": "Question", "name": "Comment gérer les symptômes d'une infection virale non classée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut le repos, l'hydratation et des médicaments pour soulager la douleur." } }, { "@type": "Question", "name": "Des traitements expérimentaux existent-ils ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux peuvent être en cours, mais leur efficacité n'est pas prouvée." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils utiles contre ces virus ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces virus ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des pneumonies, des défaillances organiques et des syndromes post-viraux." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications varient selon le virus et l'état de santé du patient." } }, { "@type": "Question", "name": "Comment gérer les complications d'une infection virale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La gestion nécessite souvent des soins intensifs et un suivi médical étroit." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par une détection précoce et un traitement approprié." } }, { "@type": "Question", "name": "Y a-t-il des risques à long terme associés ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent développer des syndromes post-viraux persistants." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour ces virus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, l'âge avancé et les maladies chroniques." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones d'épidémie augmente le risque d'exposition." } }, { "@type": "Question", "name": "Le contact avec des animaux est-il un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains virus non classés peuvent être zoonotiques, se transmettant des animaux à l'homme." } }, { "@type": "Question", "name": "Les conditions de vie influencent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conditions de vie surpeuplées ou insalubres augmentent le risque d'infection." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées et les jeunes enfants sont souvent plus vulnérables." } } ] } ] }

Sources (10000 au total)

Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis.

Opioid overdoses are a leading cause of preventable death in the United States. There is limited research linking decedents' receipt of controlled substances and presence of controlled substances on p... We linked data on opioid-detected deaths in Connecticut between May 3, 2016, and December 31, 2017 from the Office of the Chief Medical Examiner, Department of Consumer Protection, and Department of M... Our analysis included 1412 opioid-detected overdose deaths. 47 % received an opioid or benzodiazepine 90 days prior to death; 36 % received an opioid and 27 % received a benzodiazepine. Concordance be... Our results suggest medically supplied opioids and benzodiazepines potentially contributed to a substantial number, though minority, of opioid-detected deaths during the study period. Efforts to reduc...

The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews.

Access to anaesthesia and surgical care is a major problem for people living in Sub-Saharan Africa. In this region, ketamine is critical for the provision of anaesthesia care. However, efforts to cont... This research is a mixed-methods study, comprising of a cross-sectional survey at the hospital level in Rwanda, and key informant interviews with experts on anaesthesia care in Sub-Saharan Africa. Dat... The survey conducted in Rwanda found that availability of ketamine and propofol was comparable at around 80%, while thiopental and inhalational agents were available at only about half of the hospital... Ketamine is critical for the provision of anaesthesia care in Sub-Saharan Africa, and its scheduling would have a significantly negative impact on its availability for anaesthesia care....

Impact of mandatory COVID-19 shelter-in-place order on controlled substance use among rural versus urban communities in the United States.

Mandatory COVID-19 shelter-in-place (SIP) orders have been imposed to fight the pandemic. They may also have led to unintended consequences of increased use of controlled substances especially among r... Call counts received by the poison control centers between October 19, 2019 and July 6, 2020 due to exposure to controlled substance (methamphetamine, opioids, cocaine, benzodiazepines, and other narc... During the study period, 2,649 counties in the United States had mandatory SIP orders. The rate of calls reporting exposure to any of the aforementioned controlled substances among the rural counties ... The mandatory SIP orders may have had an unintended consequence of exacerbating the use of controlled substances at home in rural communities relative to urban communities....

Cardiopulmonary and muscular effects of different doses of high-intensity physical training in substance use disorder patients: study protocol for a block allocated controlled endurance and strength training trial in an inpatient setting.

Patients with substance use disorder (SUD) have high prevalence of lifestyle-related comorbidities. Physical exercise is known to yield substantial prophylactic impact on disease and premature mortali... This study will recruit 40 in-patients of mixed genders, aged 18-70 years. Participants will be block allocated to low-dose or high-dose training, encompassing 24 high-intensity interval and maximal s... This protocol is in accordance with the Standard Protocol Items: Recommendations for Interventional Trials statement. All participants will sign a written informed consent. The Regional Committee of M... NCT04065334....

Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.

New psychoactive substances (NPS) are not controlled under the Single Convention on Narcotic Drugs of 1961 or the 1971 Convention, but they may pose a public health threat. Knowledge of the main prope... We carried out a literature review collecting information on the acute, chronic, and post-mortem toxicity of these classes of NSP. We searched info in five scientific databases considering works from ... Results have shown a general lack of studies in this field given that many NPS have not had their toxicity evaluated. We observed a significant difference in the volume of data concerning acute and ch... More in-depth information about the main threats involving NPS use are needed....

Does electronic prescribing of controlled substances deter controlled substance prescribing in emergency departments?

To examine the association between electronic prescribing of controlled substances (EPCS) and controlled substance prescription patterns in U.S. emergency departments (ED).... We conducted cross-sectional analysis at both the ED level and visit level, using the 2016-2017 National Hospital Ambulatory Medical Care Surveys.... The sample included 24,296 visits to 316 EDs, 45% of which utilized EPCS. Pain-related visits were associated with significantly higher odds of prescriptions for any controlled substances (OR = 1.52; ... While EPCS transmits prescriptions directly to pharmacies in order to reduce drug diversion problems, the results indicated no significant association between EPCS use and prescriptions for Schedule I... EPCS does not appear to deter Schedule II controlled substances prescription including opioids in an ED visit. It may facilitate any and Schedule III controlled substance prescriptions when pain was i...